Literature DB >> 15451152

Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry.

Christina Steger1, Angelika Pratter, Monika Martinek-Bregel, Marion Avanzini, Andreas Valentin, Jörg Slany, Claudia Stöllberger.   

Abstract

AIMS: Stroke patients with atrial fibrillation (AF) have a poorer neurological outcome than stroke patients without AF. Whether stroke patients with AF also have a higher rate of medical complications is unknown. The aim of the study was to compare the in-hospital course of acute stroke patients with and without AF. METHODS AND
RESULTS: The Austrian Stroke registry was a prospective multi-centre study involving 57 medical departments documenting the hospital course of consecutive stroke patients from June 1999 to October 2000. AF was diagnosed in 304 (31%) of 992 patients. Patients with AF were older (79 versus 75 years, p < 0.0004) than no-AF patients. There were more cases of pneumonia (23% versus 9%, p < 0.0004), pulmonary oedema (12% versus 6%, p < 0.0004) and symptomatic intracerebral haemorrhage (8% versus 2%, p < 0.0004) in AF compared to no-AF. In-hospital mortality was higher in AF (25% versus 14%, p < 0.0004), and neurological outcome was poorer (65 versus 90 Barthel index, p < 0.0004). On multivariable logistic regression analysis, however, AF was no predictor for mortality, but a Barthel index of zero (odds ratio 5.30, 95% CI 3.10-9.08, p < 0.0001), a National Institutes of Health Stroke Scale > 21 or comatose (odds ratio 3.13, 95% CI 2.26-4.32, p < 0.0001), age > 75 years (odds ratio 3.15, 95% CI 1.85-5.37, p < 0.0001), heart rate > 100 min(-1) (odds ratio 2.15, 95% CI 1.26-3.66, p = 0.0049), obstructive pulmonary disease (odds ratio 2.58, 95% CI 1.03-6.48, p = 0.0442) and creatinine > 125 micromol/l (odds ratio 1.84, 95% CI 1.00-3.37, p = 0.0479).
CONCLUSION: Stroke in AF is associated with a poor prognosis, an increased rate of medical and neurological complications and a higher in-hospital mortality than in no-AF.

Entities:  

Mesh:

Year:  2004        PMID: 15451152     DOI: 10.1016/j.ehj.2004.06.030

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  68 in total

Review 1.  Antithrombotic treatment in atrial fibrillation.

Authors:  G Y H Lip; C J Boos
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

2.  Selection of Warfarin or One of the New Oral Antithrombotic Agents for Long-Term Prevention of Stroke among Persons with Atrial Fibrillation.

Authors:  Qinmei Xiong; Gregory Y H Lip
Journal:  Curr Treat Options Neurol       Date:  2015-02       Impact factor: 3.598

Review 3.  Ischemic stroke in the elderly: an overview of evidence.

Authors:  Ruo-Li Chen; Joyce S Balami; Margaret M Esiri; Liang-Kung Chen; Alastair M Buchan
Journal:  Nat Rev Neurol       Date:  2010-04-06       Impact factor: 42.937

4.  Influence of Age on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage.

Authors:  Aditi Shendre; Gaurav M Parmar; Chrisly Dillon; Timothy Mark Beasley; Nita A Limdi
Journal:  Pharmacotherapy       Date:  2018-02-27       Impact factor: 4.705

5.  Evaluation of anticoagulation use and subsequent stroke in patients with atrial fibrillation after empiric surgical left atrial appendage closure: A retrospective case-control study.

Authors:  Daniel O Johnsrud; Rowlens M Melduni; Brian Lahr; Xiaoxi Yao; Kevin L Greason; Peter A Noseworthy
Journal:  Clin Cardiol       Date:  2018-12-10       Impact factor: 2.882

6.  Heart failure in acute ischemic stroke.

Authors:  Angel Ois; Meritxell Gomis; Elisa Cuadrado-Godia; Jordi Jiménez-Conde; Ana Rodríguez-Campello; Jordi Bruguera; Lluis Molina; Josep Comin; Jaume Roquer
Journal:  J Neurol       Date:  2008-03-19       Impact factor: 4.849

7.  TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT).

Authors:  Danielle E Smith; Christian Borg Xuereb; Helen M Pattison; Gregory Y H Lip; Deirdre A Lane
Journal:  BMC Cardiovasc Disord       Date:  2010-05-20       Impact factor: 2.298

8.  Oral anticoagulation in elderly patients as secondary prevention of cardioembolic strokes.

Authors:  Lorena Benavente; Sergio Calleja; Vanessa de la Vega; Jorge García; Carlos H Lahoz
Journal:  Int Arch Med       Date:  2010-06-05

9.  Atrial fibrillation in patients with ischemic stroke: A population-based study.

Authors:  Sandra Kruchov Thygesen; Lars Frost; Kim A Eagle; Søren Paaske Johnsen
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

Review 10.  Cardioversion in atrial fibrillation. Focus on recent-onset atrial fibrillation.

Authors:  Andrea Tampieri; Anna Maria Rusconi; Tiziano Lenzi
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.